The survey will help to determine how patients take medication side effects into consideration...
Hollywood, Calif. (PRWEB) September 30, 2014
Bill Bro, CEO of the Kidney Cancer Association (KCA), the world’s largest charity dedicated to the eradication of death and suffering from renal cancers, said, “We’re pleased to have the opportunity to collaborate in this research aimed at answering some important questions, and we’re glad that the sponsors are willing to contribute funds to the KCA.”
This survey will help to determine how patients take medication side effects into consideration when making treatment choices. Questions are designed for patients to consider hypothetical medications with different types of side effects for comparison.
The survey seeks kidney cancer patients 18 years of age or older to participate in an online survey. The survey takes approximately 20 minutes to complete and will be open until October 20, 2014.
The Kidney Cancer Association will receive $20 per each respondent. All responses will be confidential. There is no obligation to participate. Those interested in participating in the survey may click this link.
The KCA is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers. It is also by far the largest organization of its kind, with members in more than 100 countries. KCA funds, promotes, and collaborates with the National Cancer Institute (NCI), American Society for Clinical Oncology (ASCO), American Urological Association (AUA), and other institutions on research projects. The charity educates families and physicians, and serves as an advocate on behalf of patients at the state and federal levels in the United States and globally.
Hollywood celebrity Denise Richards is a director of the charity and works to raise funds and promote awareness. Richards lost her mother to kidney cancer in 2007.